KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Tenet Healthcare (THC) Depreciation & Amortization (IS) (2016 - 2025)

Tenet Healthcare's Depreciation & Amortization (IS) history spans 17 years, with the latest figure at $218.0 million for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (IS) rose 4.31% year-over-year to $218.0 million; the TTM value through Sep 2025 reached $826.0 million, down 1.78%, while the annual FY2025 figure was $863.0 million, 5.5% up from the prior year.
  • Depreciation & Amortization (IS) for Q3 2025 was $218.0 million at Tenet Healthcare, up from $206.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $224.0 million in Q1 2021 and bottomed at $193.0 million in Q4 2024.
  • The 5-year median for Depreciation & Amortization (IS) is $211.0 million (2021), against an average of $211.6 million.
  • The largest YoY upside for Depreciation & Amortization (IS) was 10.34% in 2021 against a maximum downside of 13.73% in 2021.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $201.0 million in 2021, then grew by 5.97% to $213.0 million in 2022, then grew by 1.41% to $216.0 million in 2023, then fell by 10.65% to $193.0 million in 2024, then increased by 12.95% to $218.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Depreciation & Amortization (IS) are $218.0 million (Q3 2025), $206.0 million (Q1 2025), and $193.0 million (Q4 2024).